Monday, January 10, 2011

Myelin Repair Foundation Identifies 40+ Possible Repurposing Opportunities for Next Generation Multiple Sclerosis Therapy | Business Wire
The analysis of publicly available data was conducted by the MRF Drug Discovery Advisory Board of outside biopharmaceutical experts to aid the Foundation in prioritizing the overwhelming number of targets generated in its funded laboratories at Stanford University, the University of Chicago, Northwestern University, Case Western Reserve University, University of California-San Francisco and the University of Melbourne, Victoria, Australia.
“From day one, we set out to find ways to accelerate the time to market for this next generation MS therapy. This analysis gives us critical information to engage read more

My Blog List

This Blog is intended to provide news and information to people living with MS, their families, caregivers, medical professionals and other stakeholders. Information/opinions contained in this blog are obtained from sources believed to be reliable, but their accuracy cannot be guaranteed. This blogger does not approve, endorse or recommend specific products or services and respects an individual’s right to make their own health management decisions. However, we can provide information to assist people in their decision process. For specific, personalized information, please consult your physician or other health care professional.